Mephenytoin
An anticonvulsant related to phenytoin used to control certain types of seizures in patients who have not responded to safer first-line antiepileptic drugs. It carries a higher risk of serious side effects compared to other seizure medications and is rarely used today.
Peso Molecular
218,2500 g/mol
LogP
1,50
TPSA
49,40 Ų
Regra dos 5 de Lipinski
Aprovado
Mecanismo de Ação
Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of seizure activity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of …
Estrutura 2D
Cite this structure
Embed this structure
SMILES
CCC1(c2ccccc2)NC(=O)N(C)C1=O
InChI
InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)
Molecular Formula
C12H14N2O2
HBD / HBA
1 / 2
Ligações Rotacionáveis
2
Átomos Pesados
16
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Perguntas frequentes
An anticonvulsant related to phenytoin used to control certain types of seizures in patients who have not responded to safer first-line antiepileptic drugs. It carries a higher risk of serious side effects compared to other seizure medications and is rarely used today.
Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of seizure activity.
Yes, Mephenytoin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL861. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 4060. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="mephenytoin"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/mephenytoin/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/mephenytoin/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/mephenytoin/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="mephenytoin"></drugfyi-drug>